Introduction

Mercachem provides a wide range of chemical services to the life sciences industry.
We specialise in exclusive synthetic and process chemistry services to support research and development programs of companies across the globe.

We have the equipment and knowledge necessary to carry out organic reactions ranging from milligram to 1 kilogram scale. Moreover, we offer parallel synthesis of focused libraries. Mercachem's process research services focus on the development of efficient production processes for selected candidates.

Press release:

 

Khondrion and Mercachem - industrial partners in a ZonMW PM-RARE grant focusing on developing new drugs to treat MELAS syndrome

Nijmegen, The Netherlands, 8 May 2012. A ZonMW grant of € 3.0 million has been awarded to a national consortium consisting of the Radboud University Nijmegen Medical Centre Khondrion and Mercachem, the two industrial partners, and three mitochondrial patient organizations (VSN, ESN and IMP). This grant will support an ambitious scientific and industrial collaboration to discover treatments for MELAS syndrome, a rare mitochondrial disease that affects both children and adults.
(download full artice)

Dr. August Wolff GmbH & Co. KG Arzneimittel and Mercachem update on drug development collaborations

Bielefeld, Germany & Nijmegen, the Netherlands – 14 March 2012. Dr. August Wolff GmbH & Co. KG Arzneimittel and Mercachem have reached important milestones in two drug development collaborations. In both projects in vivo proof of concept has been shown, moreover in one of them a preclinical candidate has been nominated. The development projects involve novel classes of molecules with potential use in dermatology. (download full article)

Mercachem announces appointment of Dr. Gerhard Müller as Senior Vice President Medicinal Chemistry

Nijmegen, the Netherlands - May 24, 2011. Mercachem is pleased to announce that Dr. Gerhard Müller has joined the management team of Mercachem as Senior Vice President Medicinal Chemistry thus supporting the strong growth of the medicinal chemistry services and projects. Gerhard will be responsible for expanding Mercachem’s activities in Medicinal Chemistry. (download full article)

Dr. August Wolff Arzneimittel GmbH & Co. KG and Mercachem B.V. start two drug development collaborations

Bielefeld, Germany & Nijmegen, the Netherlands – August 26, 2010. Dr. August Wolff GmbH & Co. KG Arzneimittel and Mercachem have started two multi-year drug development collaborations. Dr. August Wolff GmbH & Co. KG Arzneimittel have licensed a number of patents from universities that cover novel classes of molecules with potential use in dermatology. Mercachem is responsible for medicinal chemistry and project management with the goal to further improve the properties of these molecules and to develop them into clinical candidates. (download full article)

Entrepreneur of the year 2010 of Nijmegen city

On 18 May 2010 the founders of Mercachem have been awarded with the title "Entrepreneur of the year 2010 of Nijmegen city" as a successful example of knowledge based entrepreneurship. Mercachem is one of the leading CRO's in Europe with nearly 110 employees in the area of (medicinal) chemistry, small molecule library services and early process R&D.

Foto: Theo van Zwam